304 related articles for article (PubMed ID: 14636827)
1. Concentration-dependent bifunctional effect of TGF-beta 1 on immunoglobulin production: a role for Smad3 in IgA production in vitro.
McKarns SC; Letterio JJ; Kaminski NE
Int Immunopharmacol; 2003 Dec; 3(13-14):1761-74. PubMed ID: 14636827
[TBL] [Abstract][Full Text] [Related]
2. Induction of liver-associated transforming growth factor beta 1 (TGF-beta 1) mRNA expression by carbon tetrachloride leads to the inhibition of T helper 2 cell-associated lymphokines.
Jeon YJ; Han SH; Yang KH; Kaminski NE
Toxicol Appl Pharmacol; 1997 May; 144(1):27-35. PubMed ID: 9169066
[TBL] [Abstract][Full Text] [Related]
3. Endogenous cytokine expression profiles in retinoic acid-induced IgA production by LPS-stimulated murine splenocytes.
Tokuyama H; Tokuyama Y
Cell Immunol; 1995 Dec; 166(2):247-53. PubMed ID: 7497526
[TBL] [Abstract][Full Text] [Related]
4. IL-21 ensures TGF-beta 1-induced IgA isotype expression in mouse Peyer's patches.
Seo GY; Youn J; Kim PH
J Leukoc Biol; 2009 May; 85(5):744-50. PubMed ID: 19168593
[TBL] [Abstract][Full Text] [Related]
5. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.
Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y
Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of transforming growth factor-beta 1 on IgA vs. IgG2b production by lipopolysaccharide-stimulated lymph node B cells: a comparative study with spleen B cells.
Garcia B; RodrÃguez R; Angulo I; Heath AW; Howard MC; Subiza JL
Eur J Immunol; 1996 Oct; 26(10):2364-70. PubMed ID: 8898946
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease.
Benahmed M; Meresse B; Arnulf B; Barbe U; Mention JJ; Verkarre V; Allez M; Cellier C; Hermine O; Cerf-Bensussan N
Gastroenterology; 2007 Mar; 132(3):994-1008. PubMed ID: 17324400
[TBL] [Abstract][Full Text] [Related]
8. Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy.
Leung JC; Chan LY; Tsang AW; Liu EW; Lam MF; Tang SC; Lai KN
Nephrol Dial Transplant; 2004 Aug; 19(8):1976-85. PubMed ID: 15187193
[TBL] [Abstract][Full Text] [Related]
9. Smad3 null mice display more rapid wound closure and reduced scar formation after a stab wound to the cerebral cortex.
Wang Y; Moges H; Bharucha Y; Symes A
Exp Neurol; 2007 Jan; 203(1):168-84. PubMed ID: 16996058
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro.
Snapper CM; Waegell W; Beernink H; Dasch JR
J Immunol; 1993 Nov; 151(9):4625-36. PubMed ID: 8409423
[TBL] [Abstract][Full Text] [Related]
11. Effect of transforming growth factor (TGF)-beta 1 on IgA isotype expression. TGF-beta 1 induces a small increase in sIgA+ B cells regardless of the method of B cell activation.
Ehrhardt RO; Strober W; Harriman GR
J Immunol; 1992 Jun; 148(12):3830-6. PubMed ID: 1602131
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta.
Yang X; Letterio JJ; Lechleider RJ; Chen L; Hayman R; Gu H; Roberts AB; Deng C
EMBO J; 1999 Mar; 18(5):1280-91. PubMed ID: 10064594
[TBL] [Abstract][Full Text] [Related]
13. [The role of transforming growth factor-beta1/Smad3 signaling in bronchiolitis obliterans following lung transplantation].
Liu HX; Li Y; Zhao CH; Liu Y; Zhang QG; Cong W; Lan XG; Xu S; Han LB; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(29):2069-73. PubMed ID: 17925182
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta 1 is a costimulator for IgA production.
Kim PH; Kagnoff MF
J Immunol; 1990 May; 144(9):3411-6. PubMed ID: 2329276
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta 1 increases IgA isotype switching at the clonal level.
Kim PH; Kagnoff MF
J Immunol; 1990 Dec; 145(11):3773-8. PubMed ID: 2246513
[TBL] [Abstract][Full Text] [Related]
16. Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation.
Feinberg MW; Shimizu K; Lebedeva M; Haspel R; Takayama K; Chen Z; Frederick JP; Wang XF; Simon DI; Libby P; Mitchell RN; Jain MK
Circ Res; 2004 Mar; 94(5):601-8. PubMed ID: 14752027
[TBL] [Abstract][Full Text] [Related]
17. Selective reduction of fibrotic markers in repairing corneas of mice deficient in Smad3.
Stramer BM; Austin JS; Roberts AB; Fini ME
J Cell Physiol; 2005 Apr; 203(1):226-32. PubMed ID: 15521071
[TBL] [Abstract][Full Text] [Related]
18. Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-beta 1.
Kim PH; Eckmann L; Lee WJ; Han W; Kagnoff MF
J Immunol; 1998 Feb; 160(3):1198-203. PubMed ID: 9570534
[TBL] [Abstract][Full Text] [Related]
19. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
20. Smad protein mediated transforming growth factor beta1 induction of apoptosis in the MDPC-23 odontoblast-like cell line.
He WX; Niu ZY; Zhao SL; Smith AJ
Arch Oral Biol; 2005 Nov; 50(11):929-36. PubMed ID: 16183370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
